Thursday, 12 May 2011 03:06am EDT
Reuters reported that Shanghai Pharmaceuticals Holding Co., Ltd. (601607.SH)will raise up to HKD16.6 billion ($2.13 billion) from its Hong Kong initial public offering (IPO). The Company plans to price its offering in a range of HKD22.5–HKD25.0 per share. Credit Suisse, Deutsche Bank and Goldman Sachs are joint global co-ordinators and book runners, while CICC is joint book runner.